Avantor, Inc., a number one international supplier of mission-critical services to clients within the life sciences and superior know-how industries, at present introduced the appointment of Simon Dingemans to its Board of Administrators, efficient January 2, 2026.
Mr. Dingemans is an achieved government with intensive international management expertise throughout healthcare, finance and strategic enterprise transformation. He was beforehand the Chief Monetary Officer of GlaxoSmithKline plc, a Associate at Goldman Sachs, and a Managing Director at The Carlyle Group. He presently serves on the boards of Vodafone Group Plc and WPP plc.
Additionally Learn: AiThority Interview That includes: Pranav Nambiar, Senior Vice President of AI/ML and PaaS at DigitalOcean
“The Board continues to take motion to speed up progress and profitability at Avantor,” stated Gregory Summe, incoming Chairman of the Avantor board. “With Simon’s breadth of expertise guiding complicated international organizations and his background in operational transformation, monetary self-discipline and strategic execution, he’s effectively suited to assist advance the Avantor Revival plan. Simon’s appointment demonstrates the Board’s dedication to discovering the most effective expertise to assist create worth for our stakeholders.”
“Avantor’s modern services have made the Firm a trusted companion to the scientific neighborhood throughout the globe,” stated Mr. Dingemans. “I look ahead to supporting the Firm’s efforts to drive operational enhancements, deepen buyer partnerships and place Avantor for sustainable, long-term success.”
